Medications for Marginal Zone Bcell Lymphoma

3 results

  • breyanzi

    (Lisocabtagene Maraleucel)
    Juno Therapeutics, Inc.
    Breyanzi is a CD19-directed CAR-T cell immunotherapy for adults with relapsed or refractory large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle cell lymphoma, or marginal zone lymphoma after 2 or more prior lines of therapy. Not indicated for primary CNS lymphoma.
    Medication Details

  • brukinsa - zanubrutinib capsule

    (Zanubrutinib)
    Beone Medicines Usa, Inc.
    BRUKINSA is a kinase inhibitor for adults with mantle cell lymphoma, Waldenström's macroglobulinemia, chronic lymphocytic leukemia or small lymphocytic lymphoma, relapsed/refractory marginal zone lymphoma, and relapsed/refractory follicular lymphoma (with obinutuzumab).
    Medication Details
    Drug Interactions

  • revlimid - lenalidomide capsule

    (Lenalidomide)
    Celgene Corporation
    Revlimid treats adult patients with multiple myeloma (with dexamethasone or as maintenance after stem cell transplant), transfusion-dependent anemia from low-risk myelodysplastic syndromes with deletion 5q, relapsed mantle cell lymphoma, and previously treated follicular or marginal zone lymphoma (with rituximab).
    Medication Details
    Drug Interactions